Ryan E. Wiegand

7k citations
166 papers · 5.1k · 4 hit papers · h-index 41

Impact in

  • Parasitology top 0.5%
    • Parasites and Host Interactions
    • SARS-CoV-2 and COVID-19 Research
    • HIV/AIDS Research and Interventions
    • Parasitic Diseases Research and Treatment

Papers in

    • SARS-CoV-2 and COVID-19 Research 38
    • Parasitic Diseases Research and Treatment 11
    • HIV/AIDS Research and Interventions 7
    • Parasites and Host Interactions 32

Ryan E. Wiegand

161 papers receiving 4.9k citations

Ryan E. Wiegand's Hit Papers

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 2024 · 153 citations
1530+1+2Years since publication50100150

Peers

Ryan E. Wiegand
Comparison fields: 5 of 152
  • Parasitology 773
  • Infectious Diseases 1.3k
  • Modeling and Simulation 222
  • Public Health, Environmental and Occupational Health 1.1k
  • Health 165
Replace Christian Bottomley with:
Christian Bottomley United Kingdom
Lyle R. Petersen United States
Wayner Vieira de Souza Brazil
Hervé Tissot‐Dupont France
Ricardo Arraes de Alencar Ximenes Brazil
Michael Libman Canada
Jennifer Erin Staples United States
Ajit Lalvani United Kingdom
Michael Marks United Kingdom
Reinhard Berner Germany
Ryan E. Wiegand relative to Christian Bottomley United Kingdom Christian Bottomley's profile →
Citations per field
00.5×2×4×6×7.0×
Christian Bottomley · 1×
Citations per year

Countries citing papers authored by Ryan E. Wiegand

Since Specialization
Citations

This map shows the geographic impact of Ryan E. Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan E. Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan E. Wiegand more than expected).

Fields of papers citing papers by Ryan E. Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan E. Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan E. Wiegand. The network helps show where Ryan E. Wiegand may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan E. Wiegand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan E. Wiegand Line = papers co-authored together Ryan E. Wiegand links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004219
2 2020207
3 2004168
4
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
Hit paper breakdown →
2024153
5 2011152
6 2015143
7
Public health impact of covid-19 vaccines in the US: observational study
Hit paper breakdown →
2022133
8 2022122
9 2020120
10
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
Hit paper breakdown →
2023101
11 200695
12 201591
13 201390
14 201587
15 200783
16 200977
17 201776
18 200470
19 202168
20 201066

About Ryan E. Wiegand

Ryan E. Wiegand is a scholar working on Infectious Diseases, Parasitology, Public Health, Environmental and Occupational Health, Modeling and Simulation and Epidemiology, having authored 166 papers that have together received 5.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (38 papers), Parasites and Host Interactions (32 papers), Malaria Research and Control (29 papers), Parasitic Diseases Research and Treatment (11 papers), COVID-19 epidemiological studies (9 papers), HIV/AIDS Research and Interventions (7 papers), Respiratory viral infections research (6 papers) and Vaccine Coverage and Hesitancy (5 papers). The work is most often cited by research in Parasitology (773 citations), Infectious Diseases (1.3k citations), Modeling and Simulation (222 citations), Public Health, Environmental and Occupational Health (1.1k citations) and Health (165 citations). Ryan E. Wiegand has collaborated with scholars based in United States, Kenya and Switzerland. Frequent co-authors include David J. Posey, Christopher J. McDougle, William Evan Secor, Susan P. Montgomery, Kimberly A. Stigler, Pauline N. M. Mwinzi, Naomi B. Swiezy, Thayne L. Sweeten, Alexandra M. Oster and Dyson A. Mwandama. Their work appears in journals such as American Journal of Tropical Medicine and Hygiene, MMWR Morbidity and Mortality Weekly Report, Malaria Journal, PLoS neglected tropical diseases and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact